MedCap AB (MEDCAP)

Currency in SEK
479.000
-10.000(-2.04%)
Real-time Data·
MEDCAP is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
478.800495.000
52 wk Range
393.000677.000
Key Statistics
Prev. Close
489
Open
486.8
Day's Range
478.8-495
52 wk Range
393-677
Volume
9.84K
Average Volume (3m)
15.14K
1-Year Change
17.6895%
Book Value / Share
96.31
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MEDCAP Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high P/E ratio relative to near-term earnings growth

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell

MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, and buyout. It prefers to invest in Biotechnology; Life sciences; Pharmaceuticals; MedTech including healthcare equipment, software, components, and packaging solutions for life science products; and Assistive Tech including digital and physical solutions in cognition, communication, environmental control, alarms, mobility, accessibility, and orthotics. The firm prefers to invest in small to medium size companies that are not listed on the stock exchange and are based in Nordic region and Northern Europe. It typically invests between SEK25 million ($2.75 million) and SEK150 million ($16.51 million) with enterprise value SEK50 million ($5.90 million) and SEK250 million ($23.06 million) and sales value between €5 million ($5.43 million) and €25 million ($27.18 million) and EBITDA between SEK1 million ($0.11 million) and SEK50 million ($5.50 million). The firm seeks to takes both minority and majority stakes. It uses its capital and loans and makes balance sheet investments. MedCap AB (publ) was founded in 2001 and is based in Stockholm, Sweden.

Compare MEDCAP to Peers and Sector

Metrics to compare
MEDCAP
Peers
Sector
Relationship
P/E Ratio
33.4x24.5x−0.4x
PEG Ratio
6.970.240.00
Price/Book
5.1x2.5x2.6x
Price / LTM Sales
3.5x3.7x3.1x
Upside (Analyst Target)
15.1%18.7%47.4%
Fair Value Upside
Unlock9.2%7.0%Unlock
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Feb 06, 2026
EPS / Forecast
4.79 / 4.86
Revenue / Forecast
591M / 552.85M
EPS Revisions
Last 90 days

MEDCAP Income Statement

People Also Watch

333.60
ADDTb
-0.89%
138.12
PME
-0.16%
76.400
SGN
+1.33%
205.2
INDT
-3.75%
130.00
MMGRb
+0.46%

FAQ

What Is the MedCap (MEDCAP) Stock Price Today?

The MedCap stock price today is 479.000 SEK.

What Stock Exchange Does MedCap Trade On?

MedCap is listed and trades on the Stockholm Stock Exchange.

What Is the Stock Symbol for MedCap?

The stock symbol for MedCap is "MEDCAP."

What Is the MedCap Market Cap?

As of today, MedCap market cap is 7.220B SEK.

What Is MedCap's Earnings Per Share (TTM)?

The MedCap EPS (TTM) is 14.668.

When Is the Next MedCap Earnings Date?

MedCap will release its next earnings report on Apr 29, 2026.

From a Technical Analysis Perspective, Is MEDCAP a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has MedCap Stock Split?

MedCap has split 1 times.

How Many Employees Does MedCap Have?

MedCap has 637 employees.

What is the current trading status of MedCap (MEDCAP)?

As of Apr 27, 2026, MedCap (MEDCAP) is trading at a price of 479.000 SEK, with a previous close of 489.000 SEK. The stock has fluctuated within a day range of 478.800 SEK to 495.000 SEK, while its 52-week range spans from 393.000 SEK to 677.000 SEK.

What Is MedCap (MEDCAP) Price Target According to Analysts?

The average 12-month price target for MedCap is 563.000 SEK, with a high estimate of 563 SEK and a low estimate of 563 SEK. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +17.54% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.